Publications

Found 383 results
2014
Del Prete GQ, Ailers B, Moldt B, Keele BF, Estes JD, Rodriguez A, Sampias M, Oswald K, Fast R, Trubey CM et al..  2014.  Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins.. Cell Host Microbe. 16(3):412-8.
Sundling C, Zhang Z, Phad GE, Sheng Z, Wang Y, Mascola JR, Li Y, Wyatt RT, Shapiro L, Karlsson Hedestam GB.  2014.  Single-Cell and Deep Sequencing of IgG-Switched Macaque B Cells Reveal a Diverse Ig Repertoire following Immunization.. J Immunol. 192(8):3637-44.
P Y Chung N, Matthews K, Kim HJ, Ketas TJ, Golabek M, Reyes Kde Los, Korzun J, Yasmeen A, Sanders RW, Klasse P J et al..  2014.  Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.. Retrovirology. 11:33.
Bird GH, Irimia A, Ofek G, Kwong PD, Wilson IA, Walensky LD.  2014.  Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.. Nat Struct Mol Biol. 21(12):1058-67.
Blattner C, Lee J H, Sliepen K, Derking R, Falkowska E, de la Peña ATorrents, Cupo A, Julien J-P, van Gils M, Lee PS et al..  2014.  Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers.. Immunity. 40(5):669-80.
Garces F, Sok D, Kong L, McBride R, Kim HJ, Saye-Francisco KF, Julien J-P, Hua Y, Cupo A, Moore JP et al..  2014.  Structural evolution of glycan recognition by a family of potent HIV antibodies.. Cell. 159(1):69-79.
West AP, Scharf L, Scheid JF, Klein F, Bjorkman PJ, Nussenzweig MC.  2014.  Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy.. Cell. 156(4):633-648.
Murin CD, Julien J-P, Sok D, Stanfield RL, Khayat R, Cupo A, Moore JP, Burton DR, Wilson IA, Ward AB.  2014.  Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy.. J Virol. 88(17):10177-88.
Pulendran B.  2014.  Systems vaccinology: probing humanity's diverse immune systems with vaccines.. Proc Natl Acad Sci U S A. 111(34):12300-6.
Crotty S.  2014.  T follicular helper cell differentiation, function, and roles in disease.. Immunity. 41(4):529-42.
Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, Bower M, Hakimpour P, Gill KP, Nakaya HI, Yarovinsky F et al..  2014.  TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination.. Immunity. 41(3):478-92.
He L, Sok D, Azadnia P, Hsueh J, Landais E, Simek M, Koff WC, Poignard P, Burton DR, Zhu J.  2014.  Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding.. Sci Rep. 4:6778.
Sharma D, Priyadarshini P, Vrati S.  2014.  Unraveling the web of viroinformatics: computational tools and databases in viral research.. J Virol.
Ravindran R, Khan N, Nakaya HI, Li S, Loebbermann J, Maddur MS, Park Y, Jones DP, Chappert P, Davoust J et al..  2014.  Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation.. Science. 343(6168):313-7.
Tran K, Poulsen C, Guenaga J, de Val N, Alda Nde Val, Wilson R, Sundling C, Li Y, Stanfield RL, Wilson IA et al..  2014.  Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign.. Proc Natl Acad Sci U S A. 111(7):E738-47.
2013
Doores KJ, Huber M, Le KM, Wang S-K, Doyle-Cooper C, Cooper A, Pantophlet R, Wong C-H, Nemazee D, Burton DR.  2013.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.. J Virol. 87(4):2234-41.
Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA.  2013.  Accelerating next-generation vaccine development for global disease prevention.. Science. 340(6136):1232910.
Kulp DW, Schief WR.  2013.  Advances in structure-based vaccine design.. Curr Opin Virol. 3(3):322-31.
Penaloza-MacMaster P, Provine NM, Ra J, Borducchi EN, McNally A, Simmons NL, Iampietro MJ, Barouch DH.  2013.  Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors.. J Virol. 87(3):1373-84.
Crispin M, Bowden TA.  2013.  Antibodies expose multiple weaknesses in the glycan shield of HIV.. Nat Struct Mol Biol. 20(7):771-2.
Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC.  2013.  Antibodies in HIV-1 vaccine development and therapy.. Science. 341(6151):1199-204.
Gruell H, Bournazos S, Ravetch JV, Ploss A, Nussenzweig MC, Pietzsch J.  2013.  Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.. J Virol. 87(15):8535-44.
Gavrilyuk J, Ban H, Uehara H, Sirk SJ, Saye-Francisco K, Cuevas A, Zablowsky E, Oza A, Seaman MS, Burton DR et al..  2013.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.. J Virol. 87(9):4985-93.
Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD et al..  2013.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.. Nature. 503(7475):277-80.
Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M et al..  2013.  Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control.. Nat Med.

Pages